Protective effect of pretreatment with cilostazol on cytotoxicity of cadmium and arsenite in cultured vascular endothelial cells
スポンサーリンク
概要
- 論文の詳細を見る
Cilostazol, an antiplatelet drug, exhibits antiatherogenic effects. The purpose of the present study was to determine the effect of cilostazol on the cytotoxicity of cadmium (Cd) and arsenite (iAsIII), which involved in the pathogenesis of vascular disorders such as atherosclerosis, in cultured vascular endothelial cells. Cytotoxicity was evaluated by the lactate dehydrogenase leakage assay and morphological observation. Cd (10 µM) -induced cytotoxicity was prevented by pretreatment with cilostazol (30 and 100 µM) and simultaneous treatment with cilostazol (100 µM). On the other hand, iAsIII-induced cytotoxicity was blocked by pretreatment with cilostazol (30 and 100 µM) but not simultaneous treatment with cilostazol. The mRNA level and the protein level of metallothionein (MT) were significantly increased by cilostazol in the cells. These results suggested, therefore, that pretreatment with cilostazol effectively prevents the cytotoxicity of Cd and iAsIII in cultured vascular endothelial cells, at least in part through the induction of MT synthesis.
論文 | ランダム
- いわゆるMCLSのわが国最初の症例について--MCLSは藤川・川崎病である (免疫とアレルギ-の最近の話題)
- 高度の好酸球増多と偏側眼球突出を伴う皮膚及び筋の多発性慢性炎症性疾患の一例に就いて
- 転換社債の意義と役割
- Klippel-Weber氏病の一例について
- 「牽牛子脂・ビサチン」による蟯虫症の治療成績